Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    November 2017
  1. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Text format     Abstract available


    October 2017
  2. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    PubMed     Text format    


    September 2017
  3. SUN X, Wang T, Zhang C, Ning K, et al
    S100A16 is a prognostic marker for colorectal cancer.
    J Surg Oncol. 2017 Sep 6. doi: 10.1002/jso.24822.
    PubMed     Text format     Abstract available


  4. SPOLVERATO G, Bagante F, Aldrighetti L, Poultsides GA, et al
    Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.
    J Surg Oncol. 2017;116:298-306.
    PubMed     Text format     Abstract available


  5. MORIS D, Tsilimigras DI, Chakedis J, Beal EW, et al
    Liver transplantation for unresectable colorectal liver metastases: A systematic review.
    J Surg Oncol. 2017;116:288-297.
    PubMed     Text format     Abstract available


  6. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    PubMed     Text format     Abstract available


    August 2017
  7. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24774.
    PubMed     Text format     Abstract available


  8. SHO S, Court CM, Winograd P, Russell MM, et al
    A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24781.
    PubMed     Text format     Abstract available


  9. STROWITZKI MJ, Schmidt T, Keppler U, Ritter AS, et al
    Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
    J Surg Oncol. 2017;116:149-158.
    PubMed     Text format     Abstract available


  10. LEE L, Alie-Cusson F, Dube P, Sideris L, et al
    Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    J Surg Oncol. 2017;116:236-243.
    PubMed     Text format     Abstract available


    July 2017
  11. ISOZAKI Y, Yamada S, Kawashiro S, Yasuda S, et al
    Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
    J Surg Oncol. 2017 Jul 20. doi: 10.1002/jso.24757.
    PubMed     Text format     Abstract available


    June 2017
  12. EMILE SH, Elfeki H, Shalaby M, Sakr A, et al
    Sensitivity and specificity of indocyanine green near-infrared fluorescence imaging in detection of metastatic lymph nodes in colorectal cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24701.
    PubMed     Text format     Abstract available


  13. TAKAHASHI H, Akyuz M, Aksoy E, Karabulut K, et al
    Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: Results of a contemporary series.
    J Surg Oncol. 2017;115:830-834.
    PubMed     Text format     Abstract available


  14. ABDELFATAH E, Page A, Sacks J, Pierorazio P, et al
    Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients.
    J Surg Oncol. 2017;115:883-890.
    PubMed     Text format     Abstract available


  15. SUAREZ J, Marin G, Vera R, Colibaseanu D, et al
    Stent placement prior to initiation of chemotherapy in patients with obstructive, nonoperative left sided tumors is associated with fewer stomas.
    J Surg Oncol. 2017;115:856-863.
    PubMed     Text format     Abstract available


  16. CHAPMAN BC, Hosokawa P, Henderson W, Paniccia A, et al
    Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.
    J Surg Oncol. 2017;115:1033-1044.
    PubMed     Text format     Abstract available


    May 2017
  17. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Text format     Abstract available


    March 2017
  18. GOMEZ-MILLAN J, Queipo MI, Del Mar Delgado M, Perez-Villa L, et al
    The impact of body mass index and nuclear beta-catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy.
    J Surg Oncol. 2017;115:301-306.
    PubMed     Text format     Abstract available


  19. IMAI K, Castro Benitez C, Allard MA, Vibert E, et al
    Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
    J Surg Oncol. 2017;115:488-496.
    PubMed     Text format     Abstract available


  20. SAXENA A, Valle SJ, Liauw W, Morris DL, et al
    Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2017;115:417-424.
    PubMed     Text format     Abstract available


  21. SUN Y, Lin H, Lu X, Huang Y, et al
    A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
    J Surg Oncol. 2017;115:462-469.
    PubMed     Text format     Abstract available


  22. CONNELL LC, Boucher TM, Chou JF, Capanu M, et al
    Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    J Surg Oncol. 2017;115:480-487.
    PubMed     Text format     Abstract available


    February 2017
  23. DOUAIHER J, Ravipati A, Grams B, Chowdhury S, et al
    Colorectal cancer-global burden, trends, and geographical variations.
    J Surg Oncol. 2017 Feb 13. doi: 10.1002/jso.24578.
    PubMed     Text format     Abstract available


  24. ARAUJO RL, Riechelmann RP, Fong Y
    Patient selection for the surgical treatment of resectable colorectal liver metastases.
    J Surg Oncol. 2017;115:213-220.
    PubMed     Text format     Abstract available


    January 2017
  25. HARAM A, Boland MR, Kelly ME, Bolger JC, et al
    The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review.
    J Surg Oncol. 2017 Jan 20. doi: 10.1002/jso.24523.
    PubMed     Text format     Abstract available


    December 2016
  26. SASAKI K, Andreatos N, Margonis GA, He J, et al
    The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    J Surg Oncol. 2016;114:803-809.
    PubMed     Text format     Abstract available


  27. KOSTNER AH, Kersten C, Lowenmark T, Ydsten KA, et al
    The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    J Surg Oncol. 2016;114:895-899.
    PubMed     Text format     Abstract available


  28. HIROSHIMA Y, Lwin TM, Murakami T, Mawy AA, et al
    Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    J Surg Oncol. 2016;114:951-958.
    PubMed     Text format     Abstract available


  29. HOKUTO D, Nomi T, Yamato I, Yasuda S, et al
    The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    J Surg Oncol. 2016;114:959-965.
    PubMed     Text format     Abstract available


    November 2016
  30. FU J, Wu L, Jiang M, Tan Y, et al
    Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    J Surg Oncol. 2016 Nov 27. doi: 10.1002/jso.24437.
    PubMed     Text format     Abstract available


  31. MCINNES MD, Nanji S, Mackillop WJ, Flemming JA, et al
    Utilization of pre-operative imaging for colon cancer: A population-based study.
    J Surg Oncol. 2016 Nov 4. doi: 10.1002/jso.24492.
    PubMed     Text format     Abstract available


  32. HU WH, Chen HH, Yen SL, Huang HY, et al
    Increased expression of interleukin-23 associated with progression of colorectal cancer.
    J Surg Oncol. 2016 Nov 3. doi: 10.1002/jso.24505.
    PubMed     Text format     Abstract available


  33. BARKHATOV L, Fretland AA, Kazaryan AM, Rosok BI, et al
    Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
    J Surg Oncol. 2016;114:757-763.
    PubMed     Text format     Abstract available


    October 2016
  34. GOVAERT JA, Govaert MJ, Fiocco M, van Dijk WA, et al
    Hospital costs of colorectal cancer surgery for the oldest old: A Dutch population-based study.
    J Surg Oncol. 2016 Oct 25. doi: 10.1002/jso.24428.
    PubMed     Text format     Abstract available


  35. KIM JC
    A universal port design for the da Vinci Xi(R) system allowing access to the entire colon for colorectal cancer surgery.
    J Surg Oncol. 2016 Oct 6. doi: 10.1002/jso.24468.
    PubMed     Text format    


  36. HONDA M, Akiyoshi T, Noma H, Ogura A, et al
    Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer.
    J Surg Oncol. 2016;114:630-636.
    PubMed     Text format     Abstract available


  37. SOUADKA A, Majbar MA, Raiss M
    Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma?
    J Surg Oncol. 2016;114:649.
    PubMed     Text format    


  38. PATEL SV, Roxburgh CS, Vakiani E, Shia J, et al
    Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2016;114:637-641.
    PubMed     Text format     Abstract available


  39. GRAVANTE G, Hemingway D, Stephenson JA, Sharpe D, et al
    Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.
    J Surg Oncol. 2016;114:642-648.
    PubMed     Text format     Abstract available


  40. LINO-SILVA LS, Garcia-Gomez MA, Salcedo-Hernandez RA
    In response: Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma.
    J Surg Oncol. 2016;114:650.
    PubMed     Text format    


    September 2016
  41. HASKINS IN, Fleshman JW, Amdur RL, Agarwal S, et al
    The impact of bowel preparation on the severity of anastomotic leak in colon cancer patients.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24426.
    PubMed     Text format     Abstract available


  42. DHIR M, Zenati MS, Padussis JC, Jones HL, et al
    Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach.
    J Surg Oncol. 2016;114:342-7.
    PubMed     Text format     Abstract available


  43. DOUMOURAS AG, Tsao MW, Saleh F, Hong D, et al
    A population-based comparison of 30-day readmission after surgery for colon and rectal cancer: How are they different?
    J Surg Oncol. 2016;114:354-60.
    PubMed     Text format     Abstract available


  44. MARGONIS GA, Kim Y, Sasaki K, Samaha M, et al
    Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
    J Surg Oncol. 2016;114:361-7.
    PubMed     Text format     Abstract available


  45. LIBERALE G, Galdon MG, Moreau M, Vankerckhove S, et al
    Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.
    J Surg Oncol. 2016;114:348-53.
    PubMed     Text format     Abstract available


  46. MASSARWEH NN, Artinyan A, Chang GJ
    Neoadjuvant treatment for rectal cancer-A value-based proposition.
    J Surg Oncol. 2016;114:304-10.
    PubMed     Text format     Abstract available


    August 2016
  47. CERCEK A, Boucher TM, Gluskin JS, Aguilo A, et al
    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
    J Surg Oncol. 2016 Aug 26. doi: 10.1002/jso.24399.
    PubMed     Text format     Abstract available


  48. FROYSNES IS, Larsen SG, Spasojevic M, Dueland S, et al
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort.
    J Surg Oncol. 2016;114:222-7.
    PubMed     Text format     Abstract available


    July 2016
  49. GRAVANTE G, Miah A, Mann CD, Stephenson JA, et al
    Circumferential resection margins and perineal complications after neoadjuvant long-course chemoradiotherapy followed by extralevator abdominoperineal excision of the rectum: Five years of activity at a single institution.
    J Surg Oncol. 2016;114:86-90.
    PubMed     Text format     Abstract available


    June 2016
  50. OKUGAWA Y, Toiyama Y, Mohri Y, Tanaka K, et al
    Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
    J Surg Oncol. 2016 Jun 28. doi: 10.1002/jso.24335.
    PubMed     Text format     Abstract available


  51. MA J, Gao Q, Zeng S, Shen H, et al
    Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-kappaB signaling.
    J Surg Oncol. 2016 Jun 23. doi: 10.1002/jso.24348.
    PubMed     Text format     Abstract available


  52. TOKODAI K, Narimatsu H, Nishida A, Takaya K, et al
    Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    J Surg Oncol. 2016 Jun 6. doi: 10.1002/jso.24320.
    PubMed     Text format     Abstract available


    May 2016
  53. PARK BK, Park JW, Han EC, Ryoo SB, et al
    Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer.
    J Surg Oncol. 2016 May 24. doi: 10.1002/jso.24299.
    PubMed     Text format     Abstract available


  54. COSTI R, Santi C, Bottarelli L, Azzoni C, et al
    Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis.
    J Surg Oncol. 2016 May 9. doi: 10.1002/jso.24282.
    PubMed     Text format     Abstract available


  55. KIM CH, Lee SY, Kim HR, Kim YJ, et al
    Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: A comparison to staging without preoperative chemoradiotherapy.
    J Surg Oncol. 2016;113:692-9.
    PubMed     Text format     Abstract available


  56. SILVESTRINI N, Coppola A, Ardito F, Nuzzo G, et al
    Anatomical liver resection of segment 4a en bloc with the caudate lobe.
    J Surg Oncol. 2016;113:665-7.
    PubMed     Text format     Abstract available


    April 2016
  57. SMITH JD, Lowery MA, Fell D, Gallagher DJ, et al
    Young patients with synchronous colorectal liver metastases.
    J Surg Oncol. 2016;113:473-6.
    PubMed     Text format     Abstract available


  58. NACHMANY I, Pencovich N, Zohar N, Goykhman Y, et al
    Resection of colorectal liver metastases in the elderly-Is it justified?
    J Surg Oncol. 2016;113:485-8.
    PubMed     Text format     Abstract available


    March 2016
  59. TAKAMOTO T, Sugawara Y, Hashimoto T, Shimada K, et al
    Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    J Surg Oncol. 2016;113:463-8.
    PubMed     Text format     Abstract available


  60. MUKKAI KRISHNAMURTY D, Wise PE
    Importance of surgical margins in rectal cancer.
    J Surg Oncol. 2016;113:323-32.
    PubMed     Text format     Abstract available


  61. BHUTIANI N, Philips P, Martin RC 2nd, Scoggins CR, et al
    Impact of surgical margin clearance for resection of secondary hepatic malignancies.
    J Surg Oncol. 2016;113:289-95.
    PubMed     Text format     Abstract available


    February 2016
  62. LYON TD, Turner Ii RM, Nikonow TN, Wang L, et al
    Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2016;113:218-22.
    PubMed     Text format     Abstract available


  63. AKYUZ M, Yazici P, Yigitbas H, Dural C, et al
    Oncologic results of laparoscopic liver resection for malignant liver tumors.
    J Surg Oncol. 2016;113:127-9.
    PubMed     Text format     Abstract available


  64. KOSKENVUO L, Peltomaki P, Renkonen-Sinisalo L, Gylling A, et al
    Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
    J Surg Oncol. 2016;113:209-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: